These results offer valuable insights for the advancement of innovative therapeutic strategies aimed at alleviating inflamed IBD and epithelial injury associated with ferroptosis, by suppressing ACSL4 expression. The gene discussed is ACSL4; the disease is inflammatory bowel disease.